Oral Gemifloxacin Versus Intravenous Cefotaxime in Treatment of Spontaneous Bacterial Peritonitis

Recruiting now · Phase 3

Conditions studied: Spontaneous Bacterial Peritonitis

In brief

oral Gemifloxacin versus intravenous Cefotaxime in treatment of spontaneous bacterial peritonitis

Key facts

Study ID

NCT04168099

Run by

Tanta University

People needed

60

Starts

2018-12-01

Expected to finish

2028-12-30

Last updated by the study team

2019-11-19

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients with spontaneous bacterial peritonitis

You may not qualify if…

• secondary peritonitis

Where it is running

• Sherief Abd-Elsalam — Tanta, Egypt (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.